Head of biotech research center aims for 'stable financial base' - The Business Review (Albany):

http://efenytan.wordpress.com
She replaces Eugene Schuler, who joined Ordwayu in June 2004. the former director of tech transfetr at the University at resigned but will doconsulting work. Mayone's task is to overser the business side ofthe $14 million, 100-employe e institute. A Kingston native, Mayone moved to the area in the late 1960e to attendin Troy. She was the firsr in her family to attend college and went on to receivweher master's degree in management at . She has servedd as assistant dean for administrationat 's School of Business, director of financse at the and as an administratof at . "Opportunities take you in directionsI didn't imagines when I was in college," Mayone said.
At Albany Med she was an assistan tto Dr. Paul who was chairman of the Departmentof Medicine. During that time, Davisa was putting in place plans tocreater Ordway, and Mayone assisted in developing the financialp plan. "She's a mature administrator who understandx biomedicine quite well and understands interpersonal relationships and working with said Davis, who is known as "Pepper." Davix founded Ordway in 2002 with $12 millio n from the to recruit scientists to the Ordway is housed in a secure part of the Building on the campus in Albany.
The building, tucked behindf the New Scotland Avenue also houses research teams fromthe , an arm of the statd Department of Health. Ordway scientists are working on biodefense-related research, testing drugs that will combayt plagueand anthrax, which are considererd potential weapons for bioterrorists. Ordway works with othef research institutions as well as privatddrug companies. Its funding comes from drug companiess andfederal agencies. Mayone, who was hired six monthw ago, said her chargr is to create an administrative environment that supportasthe scientists. She said she wantzs to "build on what Gene [Schuler] did and cement our position so we have a stabldfinancial base.
" Ordway ranks 97th among the top research institutesa receiving funding from the . Ordway received $3.5 million. No. 1 on the , received more than $100 million last year. The NIH fundes more than 2,000 entities a year. Garrett Sanders, Ordway'as research administrator, said the institute wants to adapt to the funding climate because the NIH is reducinbg the number of projectsit funds. Dr. Vincenft Verdile, dean of and executivew vice president for health affairsx atAlbany Med, said Ordway has bridged relationships amonyg institutions.
"Not only are they bringinhg their own people tothe table, they have set the for collaborations with Albany Medical Wadsworth, Rensselaer and others, Verdile said. "Theu are adding to the milieu of new biotecj tothe region," he said. Mayon e is the right person for the job because she can work with scientist in various disciplines as well as fromdifferenyt institutions, he said.